Characterization of the Plasmidome Encoding Carbapenemase and Mechanisms for Dissemination of Carbapenem-Resistant

Enterobacteriaceae IMP-1 IMP-6 carbapenem resistance carbapenemase chromosomal integration heteroresistance plasmid analysis plasmid dynamics plasmidome

Journal

mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636

Informations de publication

Date de publication:
10 Nov 2020
Historique:
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 12 11 2020
Statut: epublish

Résumé

Carbapenem-resistant

Identifiants

pubmed: 33172969
pii: 5/6/e00759-20
doi: 10.1128/mSystems.00759-20
pmc: PMC7657596
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

Copyright © 2020 Abe et al.

Références

Sci Rep. 2015 Feb 10;5:8365
pubmed: 25666585
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29610206
Antimicrob Agents Chemother. 1994 Jan;38(1):71-8
pubmed: 8141584
J Clin Microbiol. 2019 Aug 26;57(9):
pubmed: 31315956
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
pubmed: 14665678
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27919898
PLoS One. 2013 Apr 29;8(4):e62774
pubmed: 23658651
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Bioinformatics. 2015 Oct 15;31(20):3350-2
pubmed: 26099265
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6948-6951
pubmed: 27600043
Jpn J Infect Dis. 2008 Jan;61(1):58-64
pubmed: 18219136
Antimicrob Agents Chemother. 2018 Nov 26;62(12):
pubmed: 30323033
J Antibiot (Tokyo). 1992 Apr;45(4):542-7
pubmed: 1592686
Antimicrob Agents Chemother. 2001 May;45(5):1343-8
pubmed: 11302793
Nat Rev Microbiol. 2010 Apr;8(4):260-71
pubmed: 20208551
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Antimicrob Agents Chemother. 2007 Jul;51(7):2324-8
pubmed: 17438042
Clin Infect Dis. 2020 Apr 07;:
pubmed: 32255490
Clin Microbiol Rev. 2015 Jul;28(3):565-91
pubmed: 25926236
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Genome Res. 2017 May;27(5):737-746
pubmed: 28100585
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Antimicrob Agents Chemother. 2015 Feb;59(2):1356-9
pubmed: 25487806
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Nat Biotechnol. 2019 May;37(5):540-546
pubmed: 30936562
Nat Microbiol. 2019 Mar;4(3):504-514
pubmed: 30742072
J Hosp Infect. 2017 Nov;97(3):212-217
pubmed: 28736270
Antimicrob Agents Chemother. 1991 Jan;35(1):147-51
pubmed: 1901695
Antimicrob Agents Chemother. 2014 Jun;58(6):3441-50
pubmed: 24709261
J Bacteriol. 1995 Nov;177(22):6352-61
pubmed: 7592409
Front Microbiol. 2020 Feb 13;11:195
pubmed: 32117184
Antimicrob Agents Chemother. 1998 May;42(5):1181-6
pubmed: 9593147
Lancet. 1999 Sep 11;354(9182):955
pubmed: 10489986
Ann N Y Acad Sci. 2019 Dec;1457(1):61-91
pubmed: 31469443
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
J Glob Antimicrob Resist. 2020 Jun;21:195-199
pubmed: 31627024
Clin Infect Dis. 2020 Apr 07;:
pubmed: 32255494
mBio. 2018 Feb 6;9(1):
pubmed: 29437920
Sci Rep. 2020 Mar 5;10(1):4139
pubmed: 32139745
PLoS One. 2018 Mar 20;13(3):e0194000
pubmed: 29558475
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311089
Front Microbiol. 2014 Oct 28;5:558
pubmed: 25389419
J Infect Chemother. 2017 Apr;23(4):224-229
pubmed: 28161293
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877
Bioinformatics. 2011 Apr 1;27(7):1009-10
pubmed: 21278367

Auteurs

Ryuichiro Abe (R)

Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Department of Anaesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yukihiro Akeda (Y)

Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan akeda@biken.osaka-u.ac.jp.
Division of Infection Control and Prevention, Osaka University Hospital, Osaka, Japan.
Division of Infection Control and Prevention, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yo Sugawara (Y)

Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Dan Takeuchi (D)

Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Yuki Matsumoto (Y)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Daisuke Motooka (D)

Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Norihisa Yamamoto (N)

Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Department of Anaesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Division of Infection Control and Prevention, Osaka University Hospital, Osaka, Japan.

Ryuji Kawahara (R)

Department of Microbiology, Osaka Institute of Public Health, Osaka, Japan.

Kazunori Tomono (K)

Division of Infection Control and Prevention, Osaka University Hospital, Osaka, Japan.
Division of Infection Control and Prevention, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuji Fujino (Y)

Department of Anaesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Shigeyuki Hamada (S)

Japan-Thailand Research Collaboration Centre on Emerging and Re-emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Classifications MeSH